Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13448 | 772 | 32.3 | 65% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
569 | 13650 | DYSTROPHIN//DUCHENNE MUSCULAR DYSTROPHY//MYOTONIC DYSTROPHY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DUCHENNE MUSCULAR DYSTROPHY | Author keyword | 20 | 11% | 23% | 175 |
2 | NORTH STAR AMBULATORY ASSESSMENT | Author keyword | 4 | 75% | 0% | 3 |
3 | REG HABILITAT | Address | 4 | 75% | 0% | 3 |
4 | METAB NEUROMUSCULAR UNIT | Address | 4 | 46% | 1% | 6 |
5 | STELLA MARIS | Address | 3 | 50% | 1% | 5 |
6 | OCCUPAT HLTH PREVENT REINTEGRAT | Address | 3 | 100% | 0% | 3 |
7 | DUCHENNE | Author keyword | 3 | 15% | 3% | 20 |
8 | MOTOR FUNCTION MEASURE | Author keyword | 3 | 60% | 0% | 3 |
9 | MUSCULAR DYSTROPHY DUCHENNE | Author keyword | 2 | 36% | 1% | 5 |
10 | CLIN CHEMBONE MINERAL METAB UNIT | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DUCHENNE MUSCULAR DYSTROPHY | 20 | 11% | 23% | 175 | Search DUCHENNE+MUSCULAR+DYSTROPHY | Search DUCHENNE+MUSCULAR+DYSTROPHY |
2 | NORTH STAR AMBULATORY ASSESSMENT | 4 | 75% | 0% | 3 | Search NORTH+STAR+AMBULATORY+ASSESSMENT | Search NORTH+STAR+AMBULATORY+ASSESSMENT |
3 | DUCHENNE | 3 | 15% | 3% | 20 | Search DUCHENNE | Search DUCHENNE |
4 | MOTOR FUNCTION MEASURE | 3 | 60% | 0% | 3 | Search MOTOR+FUNCTION+MEASURE | Search MOTOR+FUNCTION+MEASURE |
5 | MUSCULAR DYSTROPHY DUCHENNE | 2 | 36% | 1% | 5 | Search MUSCULAR+DYSTROPHY++DUCHENNE | Search MUSCULAR+DYSTROPHY++DUCHENNE |
6 | COLOR CODED MAPS | 2 | 67% | 0% | 2 | Search COLOR+CODED+MAPS | Search COLOR+CODED+MAPS |
7 | FUNCTIONAL RATING SCALES | 2 | 67% | 0% | 2 | Search FUNCTIONAL+RATING+SCALES | Search FUNCTIONAL+RATING+SCALES |
8 | MRC SCALE | 2 | 67% | 0% | 2 | Search MRC+SCALE | Search MRC+SCALE |
9 | MUSCLE FAT FRACTION | 2 | 50% | 0% | 3 | Search MUSCLE+FAT+FRACTION | Search MUSCLE+FAT+FRACTION |
10 | DEFLAZACORT | 2 | 12% | 2% | 12 | Search DEFLAZACORT | Search DEFLAZACORT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STAR AMBULATORY ASSESSMENT | 18 | 83% | 1% | 10 |
2 | DEFLAZACORT TREATMENT | 17 | 70% | 2% | 14 |
3 | NEUROMUSCULAR DISEASES | 11 | 22% | 6% | 44 |
4 | DEFLAZACORT | 9 | 26% | 4% | 31 |
5 | CLINICAL ASSESSMENTS | 9 | 55% | 1% | 11 |
6 | LONG TERM BENEFIT | 8 | 37% | 2% | 18 |
7 | PROGRESSIVE NEUROMUSCULAR DISEASE | 8 | 41% | 2% | 15 |
8 | RESISTANCE EXERCISE PROGRAM | 7 | 42% | 2% | 13 |
9 | HOME NOCTURNAL VENTILATION | 7 | 38% | 2% | 15 |
10 | PREDNISONE THERAPY | 5 | 18% | 3% | 25 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management | 2010 | 306 | 69 | 39% |
Glucocorticoid corticosteroids for Duchenne muscular dystrophy | 2008 | 100 | 78 | 54% |
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy | 2012 | 13 | 33 | 91% |
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care | 2010 | 179 | 114 | 29% |
The role of corticosteroids in muscular dystrophy: A critical appraisal | 2007 | 59 | 43 | 60% |
A review of nutrition in Duchenne muscular dystrophy | 2009 | 22 | 74 | 51% |
The cooperative international neuromuscular research group duchenne natural history studya longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used | 2013 | 11 | 79 | 44% |
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the US Food and Drug Administration | 2015 | 0 | 3 | 100% |
Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool | 2006 | 24 | 19 | 53% |
PROFILES OF NEUROMUSCULAR DISEASES | 1995 | 137 | 57 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REG HABILITAT | 4 | 75% | 0.4% | 3 |
2 | METAB NEUROMUSCULAR UNIT | 4 | 46% | 0.8% | 6 |
3 | STELLA MARIS | 3 | 50% | 0.6% | 5 |
4 | OCCUPAT HLTH PREVENT REINTEGRAT | 3 | 100% | 0.4% | 3 |
5 | CLIN CHEMBONE MINERAL METAB UNIT | 2 | 67% | 0.3% | 2 |
6 | GARCHES | 2 | 67% | 0.3% | 2 |
7 | MED CARING | 2 | 67% | 0.3% | 2 |
8 | MED PMR | 2 | 67% | 0.3% | 2 |
9 | MRC NEUROMUSCULAR DIS NEWCASTLE | 2 | 67% | 0.3% | 2 |
10 | SG BATTISTA HOSP | 2 | 26% | 0.8% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000271352 | MDX MICE//DUCHENNE MUSCULAR DYSTROPHY//MDX |
2 | 0.0000199524 | MECHANICAL INSUFFLATION EXSUFFLATION//PEAK COUGH FLOW//EXSUFFLATION |
3 | 0.0000177701 | FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY//FSHD//D4Z4 |
4 | 0.0000165164 | NEUROMUSCULAR SCOLIOSIS//KYPHECTOMY//PELVIC OBLIQUITY |
5 | 0.0000147358 | GOWERS//QUEEN SQ ARCH MUSEUM//QUEEN SQ LIB |
6 | 0.0000142208 | ELECTRICAL IMPEDANCE MYOGRAPHY//MUSCLE ULTRASOUND//CENTRAL HYPOTONIA |
7 | 0.0000131862 | DYSTROPHIN//BECKER MUSCULAR DYSTROPHY//DUCHENNE MUSCULAR DYSTROPHY |
8 | 0.0000129663 | SINCERITY OF EFFORT//SUBMAXIMAL EFFORT//DYNAMOMETRY |
9 | 0.0000125674 | EXON SKIPPING//DMD GENET THER Y GRP//MC LOCKWOOD MUSCULAR DYSTROPHY |
10 | 0.0000111828 | REHABIL INFANTIL//MURINE MUSCULAR DYSTROPHY//HUMAN MUSCLE CELL CULTURES |